期刊文献+

胶质瘤中血管内皮生长因子受体FLT-1和KDR mRNA表达的差异及其与肿瘤病理的关系 被引量:1

Different expression of VEGF receptor KDR and FLT-1 mRNA and its correlation with gliomas
下载PDF
导出
摘要 目的 探讨胶质瘤中血管内皮生长因子 (VEGF)受体KDR和FLT 1的基因表达水平及其与肿瘤病理的关系。方法 应用逆转录PCR(reversetranscriptionpolymerasechainreaction ,RT PCR)方法检测 4 3例胶质瘤和 5例正常脑组织标本中KDR和FLT 1的基因表达情况 ,结合凝胶分析仪半定量的检测肿瘤标本中特异性mR NA的含量 ,并与肿瘤的临床病理进行比较。结果 电泳结果 :FLT 1在 6 4 5bp左右可见一明亮的条带 ;而KDR在1 0 0 0bp以上 (1 2 4 1bp)可见一明亮的条带 ,其亮度均随肿瘤级别的升高而升高。FLT 1mRNA的相对含量Ⅰ~Ⅳ级依次为 :0 .6 4± 0 .0 8、0 .86± 0 .1 0、1 .2 3± 0 .0 6、1 .37± 0 .0 6 ;正常脑组织为 0 .34± 0 .0 4。KDRmRNA的相对含量Ⅰ~Ⅳ级依次为 :0 .70± 0 .0 8、0 .92± 0 .1 1、1 .6 2± 0 .36、2 .86± 0 .30 ,正常脑组织为 0 .4 0± 0 .0 7。VEGF两种受体mRNA的相对含量随肿瘤级别的增加而增加 ,有显著性差异 (P <0 .0 0 0 1 )。结论 两种受体之间的差异明显 ,总的来说 ,KDR要比FLT 1的mRNA含量高 ,而随着胶质瘤恶性程度的增加 ,这种差别明显增大 ,尤其在胶质母细胞瘤中 ,KDR的平均相对mRNA含量是FLT 1的 Objective To evaluate the different expression of VEGF receptors (KDR and FLT 1) mRNA in gliomas.Methods 43 glioma specimens and 5 normal brain tissues were studied using RT PCR,and gel analysis system is used to semi quantity mRNA abundance in gliomas.These results were analyzed with pathological findings of the tumors.Results The expression of FLT 1 mRNA corresponded to amplification product 645bp.The relative mRNA abundance (ratio of intensity of FLT 1/β actin) was:grade Ⅰ 0.64±0.08,grade Ⅱ 0.86±0.10,grade Ⅲ 1.23± 0.06 ,grade Ⅳ 1.37± 0.06 ,normal brain tissues 0.34±0.04.The expression of KDR mRNA corresponded to amplification product of 1241 bp.The mRNA relative concentration is grade Ⅰ 0.70±0.08,grade Ⅱ 0.92±0.11,grade Ⅲ 1.62±0.36,grade Ⅳ 2.86±0.30,normal brain tissues 0.40±0.07.Conclusions The relative mRNA abundance of the two VEGF receptors was increased with the grade of gliomas.Statistics with one way ANOV, P <0.001.It indicates that the difference of VEGF receptors mRNA expression between different grade gliomas is significant.
出处 《北京医学》 CAS 北大核心 2004年第1期10-13,共4页 Beijing Medical Journal
关键词 胶质瘤 血管内皮生长因子受体 FLT-1基因 KDR基因 肿瘤病理学 逆转录PCR Glioma angiogenesis VEGF receptor Pathology
  • 相关文献

参考文献8

  • 1Watenbenberger J,Clasesson-Welsh L,Siegbahn A,et al.Different signal transduction properties od KDR and FLt-1, two receptors for vascular endothelial growth factor[].Journal of Biochemistry.1994
  • 2Hewett PW.Coexpression of FLt-1, FLt-4 and KDR in freshly isolated and cultured human endothelial cells[].Biochemical and Biophysical Research Communications.1996
  • 3Ferrara N.Vascular endothelial growth factor[].European Journal of Cancer.1996
  • 4Seetharam L,Gotoh N,Maru Y,et al.A unique signal transduction pathway for the FLT tyrosine kinase, a receptor for vascular endothelial growth factor[].Oncegene.1995
  • 5Keyt B,Nguyen H,Berleau L,et al.Identification of VEGF determinants for binding FLT-1 and KDR receptors.Generation of receptorselective VEGF variants by site-directed mutagenesis[].Journal of Biochemistry.1996
  • 6Park JE,Chen H,Winer J,et al.Placenta growth factor.Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo,and high affinity binding to FLT-1 but not to FLK-1/KDR[].Journal of Biological Chemistry.1994
  • 7Annie SY,Leung SY,Wong MP.Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma[].The American Journal of Surgical Pathology.1998
  • 8Plate KH,Breier G,Weich HA,et al.VEGF is a potential tumor angiogenesis factor in human glioma in vivo[].Nature.1992

同被引文献18

  • 1索新,郭永川,孟令秋,郭宏川.血管内皮生长因子在人脑胶质瘤的定位及表达[J].中华实验外科杂志,2004,21(9):1100-1102. 被引量:8
  • 2Nagashima G,Suzuki R,Asai J I,et al.Tissue reconstruction process in the area of peri-tumoural oedema caused by glioblastoma-immunohistochemical and graphical analysis using brain obtained at autopsy[J].Acta Neurochir Suppl,2003,86:507-511.
  • 3Zhou Y H,Tan F,Hess K R,et al.The expression of PAX6,PTEN,vascular endothelial growth factor and epidermal factor receptor in gliomass relationship to tumor grade and surrvival[J].Clin Cancer Res,2003,9(9):3369-3375.
  • 4Guo P,Xu L,Pan S,et al.Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites[J].Cancer Res,2001,61(23):8569-8577.
  • 5Yonemura Y,Endo Y,Fujita H,et al.Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer[J].Clin Cancer Res,1999,5(7):1823-1829.
  • 6Tsurusaki T,Kanda S,Sasaki H,et al.Vascular endothelial growth factor-C expression in human prostatic cancer and its relationship to lymph node metastasis[J].Br J Cancer,1999,80(1-2):309-313.
  • 7Niki T,Iba S,Tokunou M,et al.Expression of vascular endothelial growth factors A,B,C and D and their relationships to lymph node status in lung adenocarcinoma[J].Clin Cancer Res,2000,6(6):2431-2439.
  • 8Tsai J C,Teng L J,Chen C T,et al.Protein kinase C mediates induced secretion of vascular endothelial growth factor by human glioma cells[J].Biochem Biophys Res Commun,2003,309(4):952-960.
  • 9Jensen R I.Growth factor mediated angiogenesis in the malignant progression of glioma tumor:a review[J].Surg Neurol,1998,49(2):189-196.
  • 10Mitsuhashi A,Sueuka K,Yamazawa K,et al.Serum vascular endothelial growth (VEGF) and VEGF-C levels as markers in patients with cervical carcinoma[J].Cancer,2005,103(4):724-730.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部